PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $12,294,000 | +328.8% | 683,381 | +69.9% | 0.02% | +183.3% |
Q1 2020 | $2,867,000 | +24.1% | 402,113 | +315.5% | 0.01% | +100.0% |
Q4 2019 | $2,311,000 | -28.7% | 96,769 | -19.9% | 0.00% | -40.0% |
Q3 2019 | $3,239,000 | +899.7% | 120,787 | +911.8% | 0.01% | – |
Q2 2019 | $324,000 | -87.2% | 11,938 | -83.7% | 0.00% | -100.0% |
Q1 2019 | $2,539,000 | -46.1% | 73,172 | -58.6% | 0.00% | -33.3% |
Q3 2018 | $4,711,000 | +416.0% | 176,916 | +532.8% | 0.01% | +500.0% |
Q1 2018 | $913,000 | +82.2% | 27,959 | +171.4% | 0.00% | 0.0% |
Q4 2017 | $501,000 | -97.9% | 10,301 | -97.7% | 0.00% | -97.3% |
Q3 2017 | $23,967,000 | +28.9% | 443,582 | +34.0% | 0.04% | +12.1% |
Q2 2017 | $18,589,000 | +41.5% | 330,941 | -1.3% | 0.03% | +37.5% |
Q1 2017 | $13,136,000 | -49.4% | 335,190 | -71.0% | 0.02% | -55.6% |
Q4 2016 | $25,969,000 | +91.1% | 1,157,279 | +93.4% | 0.05% | +134.8% |
Q3 2016 | $13,587,000 | -39.2% | 598,256 | -36.8% | 0.02% | -54.9% |
Q2 2016 | $22,332,000 | +36.6% | 946,269 | +18.1% | 0.05% | +24.4% |
Q1 2016 | $16,352,000 | -82.4% | 801,555 | -55.6% | 0.04% | -79.0% |
Q4 2015 | $92,975,000 | +80.5% | 1,807,082 | +49.6% | 0.20% | +97.0% |
Q3 2015 | $51,498,000 | +169.0% | 1,208,315 | +187.4% | 0.10% | +175.0% |
Q2 2015 | $19,147,000 | -28.7% | 420,359 | -40.6% | 0.04% | -28.0% |
Q1 2015 | $26,863,000 | +161.5% | 707,669 | +95.1% | 0.05% | +127.3% |
Q4 2014 | $10,274,000 | -14.8% | 362,791 | -23.9% | 0.02% | -26.7% |
Q3 2014 | $12,053,000 | +152.5% | 476,776 | +191.5% | 0.03% | +130.8% |
Q2 2014 | $4,773,000 | -10.8% | 163,578 | -20.8% | 0.01% | -18.8% |
Q1 2014 | $5,351,000 | +902.1% | 206,587 | +896.1% | 0.02% | +700.0% |
Q4 2013 | $534,000 | -87.0% | 20,740 | -86.5% | 0.00% | -84.6% |
Q3 2013 | $4,122,000 | -16.6% | 154,098 | -23.4% | 0.01% | -13.3% |
Q2 2013 | $4,942,000 | – | 201,123 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|